MAIA Biotechnology, Inc.MAIANYSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+1065.3%
5Y CAGR+345.1%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+1065.3%/yr
Annual compound
5Y CAGR
+345.1%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1747.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$9.72B+139830.6%
2024$6.95M-23.4%
2023$9.07M+47.6%
2022$6.14M+43.2%
2021$4.29M-22.9%
2020$5.56M+11.1%
2019$5.01M-